Skip to content

Research

Macular atrophy development in patients treated with anti-VEGFs show a clear association with subretinal drusenoid deposits.

Researchers based at New York University School of Medicine have published research confirming an association between subretinal drusenoid deposits (SDD) and macular atrophy (MA) in… Read More »Macular atrophy development in patients treated with anti-VEGFs show a clear association with subretinal drusenoid deposits.

Research published in Ophthalmologica shows aflibercept “treat and extend” (TAE) protocol is efficacious in typical AMD patients.

Research, reported in EURETINA’s professional journal, Ophthalmologica, has shown that a treat-and-extend (“TAE”) regimen using aflibercept for typical AMD appears effective for improving AMD and… Read More »Research published in Ophthalmologica shows aflibercept “treat and extend” (TAE) protocol is efficacious in typical AMD patients.

Expert research scientists in demand to support evaluation of new drug approvals for novel technologies, including retinal stem cell and gene therapies

A Nature editorial has called for increased support from research scientists into translational medicine, specifically in regards to cutting edge and novel technologies now seeking… Read More »Expert research scientists in demand to support evaluation of new drug approvals for novel technologies, including retinal stem cell and gene therapies